{"product_id":"che-swot-analysis","title":"(CHE) Chemed Corporation SWOT Analysis Research","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-List-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eValidate Every Claim with the Complete Sources File\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThis Chemed Corporation SWOT Analysis gives a concise, company-specific view of strengths, weaknesses, opportunities, and threats to support research, strategy, or investment decisions. This page includes a real preview\/sample of the actual analysis so you can judge format and depth before buying. Purchase the full version to download the complete, ready-to-use report.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eStrengths\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e2 operating divisions: VITAS and Roto-Rooter\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eChemed Corporation’s two operating divisions, VITAS and Roto-Rooter, spread revenue across healthcare and property services, cutting dependence on one end market. In 2024, Chemed generated about $2.1 billion in revenue, with VITAS contributing roughly $1.7 billion and Roto-Rooter about $586 million. That mix gives Chemed exposure to recurring hospice care demand and essential home repair demand.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNationwide hospice and palliative care reach\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVITAS gives Chemed nationwide hospice and palliative care reach, operating in 15 states and the District of Columbia. It serves about 23,000 patients daily, so the business is tied to steady end-of-life demand from an aging U.S. population. That scale strengthens brand awareness and supports operating leverage in a specialized, high-need care niche.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEssential service mix\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eChemed Corporation’s mix is built on non-deferrable demand: VITAS provides medically necessary hospice care, while Roto-Rooter handles urgent plumbing and water-damage jobs. In 2024, Chemed generated about $2.3 billion in revenue, and that need-based split helps cushion volume across weak or strong economic periods. Customers can delay many buys, but these services usually cannot wait.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eLarge skilled workforce model\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eChemed Corporation’s large skilled workforce is a real edge: its care teams include physicians, registered nurses, home health aides, social workers, spiritual advisors, volunteers, and trades professionals. That mix supports higher-touch service, builds trust, and makes Chemed harder to match than smaller local providers. In FY2024, Chemed generated $2.2 billion in revenue.\u003c\/p\u003e\n\u003cp\u003eWith roughly 15,000 employees across VITAS and Roto-Rooter, Chemed can cover complex care needs and field demand at scale. This depth helps it deliver more consistent service and protect margins through better staffing reach.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMulti-role care teams\u003c\/li\u003e\n\u003cli\u003eStronger patient trust\u003c\/li\u003e\n\u003cli\u003eBetter operational scale\u003c\/li\u003e\n\u003cli\u003eFY2024 revenue: $2.2B\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eEstablished since 1970\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eChemed Corporation has operated since 1970, giving it 55 years of history and a long track record across the 2025 fiscal year. That kind of tenure usually points to mature processes, durable brand trust, and seasoned management, which matters in healthcare and service-heavy businesses. Its Cincinnati headquarters also signals a stable corporate base, while Chemed reported $2.3 billion in 2025 revenue, showing the scale that often comes with long operating history.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFounded in 1970; 55 years of history\u003c\/li\u003e\n\u003cli\u003eStable Cincinnati headquarters\u003c\/li\u003e\n\u003cli\u003e2025 revenue: $2.3 billion\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChemed’s Two-Engine Model Powers Steady Cash Flow\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eChemed Corporation’s strengths come from two non-deferrable businesses: VITAS hospice care and Roto-Rooter emergency plumbing. In 2025, Chemed reported about $2.3 billion in revenue, with VITAS at roughly $1.8 billion and Roto-Rooter near $0.6 billion, showing balanced cash flow across healthcare and home services. Its national hospice reach and skilled labor base support scale, trust, and recurring demand.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal revenue\u003c\/td\u003e\n\u003ctd\u003e$2.3B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVITAS revenue\u003c\/td\u003e\n\u003ctd\u003e$1.8B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"product-includes\"\u003e\n\u003cdiv class=\"product-includes__container\"\u003e\n\u003ch2 id=\"product-includes-title\" class=\"product-includes__title\"\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-includes__grid\"\u003e\n\u003cdiv class=\"include-card\"\u003e\n\u003cdiv class=\"include-card__icon-wrap\"\u003e\n\u003cimg class=\"include-card__icon\" src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Detailed Word Document icon\"\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"include-card__heading\"\u003e\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp class=\"include-card__text\"\u003eProvides a clear SWOT framework for analyzing Chemed Corporation’s business strategy\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"include-card\"\u003e\n\u003cdiv class=\"include-card__icon-wrap\"\u003e\n\u003cimg class=\"include-card__icon\" src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Customizable Excel Spreadsheet icon\"\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"include-card__heading\"\u003e\u003cstrong\u003eEditable Excel File\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp class=\"include-card__text\"\u003eDelivers a clear, concise Chemed Corporation SWOT snapshot to quickly surface risks, strengths, and strategic priorities.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"include-card\"\u003e\n\u003cdiv class=\"include-card__icon-wrap\"\u003e\n\u003cimg class=\"include-card__icon\" src=\"\/cdn\/shop\/files\/GENERAL-Reference-Icon.svg\" alt=\"References icon\"\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"include-card__heading\"\u003e\u003cstrong\u003eReference Sources\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp class=\"include-card__text\"\u003eProvides a concise bibliography of primary industry reports, regulatory filings, and trusted benchmarks to validate Chemed Corporation assumptions and speed due diligence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eWeaknesses\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh labor dependence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eChemed Corporation’s VITAS and Roto-Rooter units depend on licensed clinicians, caregivers, technicians, and contractors, so staffing gaps can hit service delivery fast. Labor shortages and wage inflation can squeeze margins, especially in hospice, where care is people-heavy and labor is the largest cost line. If staffing slips, quality and compliance can weaken at the same time.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExposure to reimbursement risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVITAS depends heavily on Medicare and other healthcare reimbursement channels, so Chemed Corporation’s earnings can swing fast if payment rules change. In 2024, Chemed Corporation reported about $2.1 billion in revenue, and any hospice rate freeze or pricing cut would pressure a business with thin margins. That makes this part of the portfolio structurally sensitive to policy shifts, not just demand trends.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOperational complexity across 2 very different businesses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eChemed Corporation's two-segment model, VITAS Hospice and Roto-Rooter, forces very different skills, systems, and oversight. That split raises coordination costs and can slow decisions, especially when one unit faces care rules and the other handles field-service operations. It also limits pure specialization, since management must balance two business models instead of one.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eLimited scale versus mega-cap peers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eChemed Corporation is still small next to mega-cap healthcare and home-services peers, with about $2.4 billion in 2025 revenue. That limits pricing power and leaves less room to spread growth across many businesses, since Chemed depends mainly on VITAS and Roto-Rooter. Smaller scale can also cap deal size and slow bolt-on M\u0026amp;A.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAbout $2.4B 2025 revenue\u003c\/li\u003e\n\u003cli\u003eTwo core operating platforms\u003c\/li\u003e\n\u003cli\u003eLess pricing power than giants\u003c\/li\u003e\n\u003cli\u003eSmaller M\u0026amp;A firepower\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eReputation sensitivity in end-of-life care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eVITAS carries outsized reputation risk because hospice care is tied to end-of-life decisions, where families, regulators, and referral partners expect near-perfect service. In Chemed Corporation's latest filings, VITAS still drives most operating profit, so even a small trust break can hit the segment fast through fewer referrals, slower admissions, and heavier scrutiny.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\u003cp\u003eHigh emotional stakes raise damage from any lapse\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eReferral loss can follow one bad care event\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eRegulatory scrutiny can amplify the hit\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChemed’s Biggest Weakness: Heavy Reliance on Two Businesses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eChemed Corporation’s biggest weakness is concentration: VITAS and Roto-Rooter drive nearly all earnings, so any hit to one unit can move the whole Company fast. VITAS also faces Medicare reimbursement risk, and Chemed Corporation’s 2025 revenue was about $2.4 billion, so it has less scale and pricing power than larger peers. Labor inflation, staffing gaps, and hospice compliance risk can pressure margins at the same time.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eWeakness\u003c\/th\u003e\n\u003cth\u003eData point\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue scale\u003c\/td\u003e\n\u003ctd\u003eAbout $2.4B in 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBusiness concentration\u003c\/td\u003e\n\u003ctd\u003e2 core operating units\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePolicy exposure\u003c\/td\u003e\n\u003ctd\u003eMedicare-driven hospice revenue\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eChemed Corporation Reference Sources\u003c\/h2\u003e\n\u003cp\u003eThis is a real excerpt from the complete Chemed Corporation SWOT analysis you'll receive upon purchase—no surprises, just professional quality and ready-to-use insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Opportunities-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eOpportunities\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eU.S. aging population\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eU.S. demographics support Chemed Corporation’s VITAS unit: the Census Bureau projects the 65+ population at about 82 million by 2050, up from about 61 million in 2024. As more Americans enter high-need years, hospice and palliative care demand should keep rising. That makes aging one of the clearest long-term tailwinds for VITAS.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigher hospice penetration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eU.S. hospice use still leaves room to grow: Medicare hospice beneficiaries were about 1.8 million in 2024, yet many eligible patients enter too late. Chemed Corporation can gain from stronger physician referrals, better awareness, and tighter care coordination, lifting patient volume without changing its model.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Opportunities-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWater damage and remediation growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMore severe weather and aging U.S. infrastructure can lift demand for water damage cleanup and emergency repairs. NOAA said the U.S. had 28 billion-dollar weather disasters in 2023, a record pace that supports more remediation calls. Roto-Rooter can use that demand to win work beyond standard plumbing jobs and grow in higher-value, urgent service lines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eDigital lead generation and scheduling\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eDigital lead generation can lift Chemed Corporation's conversion at Roto-Rooter, where faster online booking and dispatch can shorten response times in a 2024 business that generated about $2.1 billion of revenue. For VITAS, smoother digital referral intake can speed hospice admissions and help support its $1.3 billion revenue base. \u003c\/p\u003e\n\u003cp\u003eBetter mobile scheduling and routing can turn more searches into paid jobs and cut empty drive time. \u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigher conversion from online leads\u003c\/li\u003e\n\u003cli\u003eFaster dispatch and response\u003c\/li\u003e\n\u003cli\u003eCleaner VITAS referral flow\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eAcquisition and franchise expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eChemed Corporation can grow by buying small local service firms and adding contractor or franchise coverage in fragmented home-services markets. In 2024, Chemed generated $2.3 billion in revenue, giving it room to fund selective deals instead of building every branch from scratch. That model can lift market share faster and lower rollout risk.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eBuy local operators in fragmented markets\u003c\/li\u003e\n\u003cli\u003eExpand contractor and franchise reach\u003c\/li\u003e\n\u003cli\u003eScale faster with less capex\u003c\/li\u003e\n\u003cli\u003eUse Chemed Corporation cash flow to fund deals\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChemed’s Aging and Storm Cleanup Tailwinds Could Lift Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eChemed Corporation can benefit from aging-driven hospice demand, with the U.S. 65+ population projected near 82 million by 2050 and Medicare hospice use at about 1.8 million in 2024. Roto-Rooter also gains from severe-weather cleanup demand, after 28 U.S. billion-dollar disasters in 2023. Digital intake, faster dispatch, and small acquisitions can lift growth at both units.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eOpportunity\u003c\/th\u003e\n\u003cth\u003eKey data\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospice growth\u003c\/td\u003e\n\u003ctd\u003e1.8M beneficiaries, 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAging tailwind\u003c\/td\u003e\n\u003ctd\u003e82M age 65+ by 2050\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStorm cleanup demand\u003c\/td\u003e\n\u003ctd\u003e28 billion-dollar disasters, 2023\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eScale-up\u003c\/td\u003e\n\u003ctd\u003e2024 revenue about $2.3B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Threats-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eThreats\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedicare and Medicaid reimbursement pressure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMedicare and Medicaid reimbursement pressure is a real threat for Chemed Corporation, because VITAS depends on government-set hospice rates that can change each year. Even a 1%–2% cut or slower update can squeeze margins fast, since care costs rise while pricing is fixed by CMS policy. This is outside VITAS’s control, so federal and state decisions remain a major earnings risk for the healthcare segment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical labor shortages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eClinical labor shortages are a real threat for Chemed Corporation, especially at VITAS, because competition for nurses and aides stays intense. The U.S. nursing gap was projected to reach 78,610 full-time RNs by 2025, keeping pay pressure high. Short staffing can cap patient volume, delay care, and raise labor costs, which can hurt margins and service quality.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Threats-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLiability and compliance risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVITAS faces tight hospice oversight, heavy documentation rules, and quality reviews, while Roto-Rooter field work adds injury and property-damage risk. In 2024, Chemed Corporation generated about $2.1 billion in revenue, so even a small billing probe, False Claims Act case, or license issue can hit cash flow and margins. Reputational damage can also hurt referral volume and local customer trust fast.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eIntense local competition in plumbing services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eRoto-Rooter faces fierce local rivals: independent plumbers, regional chains, and franchise operators. In routine drain cleaning and repairs, price cuts can squeeze margins fast because customers can switch in one call and many jobs are small-ticket, repeatable, and easy to compare. That makes service quality and response time as important as price.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLow switching costs\u003c\/li\u003e\n\u003cli\u003eHeavy price pressure\u003c\/li\u003e\n\u003cli\u003eFragmented local market\u003c\/li\u003e\n\u003cli\u003eMargin risk on routine jobs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eChemed must keep spending on branding, dispatch speed, and technician productivity to defend share.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eEconomic and weather volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eChemed Corporation’s home-service demand can soften when consumer spending weakens, since Roto-Rooter jobs are often discretionary and timing can slip. Weather adds a second swing factor: NOAA counted 28 U.S. billion-dollar disasters in 2023, showing how storms can both spike emergency calls and disrupt crews, so quarterly results can move sharply.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eWeak spending can delay non-urgent service work\u003c\/li\u003e\n\u003cli\u003eStorms can lift demand, then block operations\u003c\/li\u003e\n\u003cli\u003eQuarterly segment results can swing fast\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChemed Faces Reimbursement, Labor, and Weather Risks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eChemed Corporation faces three main threats: Medicare and Medicaid rate pressure at VITAS, labor scarcity, and tighter hospice oversight. In 2024, Chemed Corporation generated about $2.1 billion in revenue, so small reimbursement or compliance shocks can move earnings fast. Roto-Rooter also faces heavy local price competition and low switching costs. Weather swings can lift demand, but NOAA counted 28 U.S. billion-dollar disasters in 2023, which can also disrupt crews.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eThreat\u003c\/th\u003e\n\u003cth\u003eData point\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eReimbursement pressure\u003c\/td\u003e\n\u003ctd\u003e~$2.1B revenue in 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLabor shortage\u003c\/td\u003e\n\u003ctd\u003e78,610 RN gap by 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeather disruption\u003c\/td\u003e\n\u003ctd\u003e28 U.S. billion-dollar disasters in 2023\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"DCF Analyst","offers":[{"title":"Default Title","offer_id":57234185781513,"sku":"che-swot-analysis","price":5.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0942\/8045\/0313\/files\/che-swot-analysis.webp?v=1785714788","url":"https:\/\/dcfanalyst.com\/products\/che-swot-analysis","provider":"DCF Analyst","version":"1.0","type":"link"}